TrialHaemophilia : the official journal of the World Federation of Hemophilia

Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A.

Priyanka Raheja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.